Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis.

Background: Numerous ongoing trials are testing anti-PD-1-based or anti-PD-L1-based cancer treatment combinations. Understanding the toxicity profiles of treatment-related adverse events is essential. The aim of this study was to comprehensively investigate the incidences and profiles of treatment-r...

Descripción completa

Detalles Bibliográficos

Publicado en:	Lancet Oncology Vol. 22; no. 9; pp. 1265 - 1275
Autores principales:	Zhou, Xiaoxiang, Yao, Zhuoran, Bai, Hua, Duan, Jianchun, Wang, Zhijie, Wang, Xin, Zhang, Xue, Xu, Jiachen, Fei, Kailun, Zhang, Zhen, Tan, Fengwei, Xue, Qi, Gao, Shugeng, Gao, Yibo, Wang, Jie, He, Jie
Formato:	research Journal Article
Publicado:	Elsevier B.V. Sep2021
Acceso en línea:	Ver este registro en EBSCOhost